MOLECULAR DEVICES REPORTS FIRST QTR '05 RECORD
REVENUES.(Molecular Devices Corp.)
Molecular Devices Corporation (NASDAQ:MDCC), Sunnyvale, Calif. has
announced record revenues and earnings for the quarter ended March 31,
2005.
Revenues for the quarter were a record $39.1 . . .
WATERS REVISES FIRST QTR 2005 SALES/EARNINGS OUTLOOK.(Brief
Article)
Waters Corporation (NYSE:WAT), Milford, Mass., has revised its
first quarter 2005 sales and earnings per diluted share (E.P.S.) outlook
due to weaker than expected sales growth. In its January 27, . . .
BIOMET REPORTS RECORD THIRD QTR SALES AND EARNINGS.
Biomet, Inc., Warsaw, Ind., has reported record sales and earnings
results for its third quarter ended February 28, 2005. Net sales
increased 18% to $482,023,000, while operating income increased . . .
CRUCELL REPORTS 2004 THREE-FOLD INCREASE OVER 2003
REVENUE.(finance)
Dutch biotechnology company Crucell N.V. (Euronext, Nasdaq: CRXL),
Leiden, The Netherlands, has announced its 2004 financial results.
Revenue for the year ended December 31, 2004 was 22.6 million . . .
MONSANTO FIRST QTR '05 OPERATIONS STRONGER THAN
ESTIMATED.
Monsanto Company (NYSE:MON), St. Louis, plans to establish a
reserve in its first-quarter 2005 results associated with the Solutia
Inc. bankruptcy proceedings. The company also announced . . .
IGI REPORTS 1ST QTR '05 PRODUCT SALES DECREASED 41%.
IGI, Inc. (AMEX:IG), Buena, N.J., has announced its first quarter
financial and operational results.
First Quarter 2005 Results
For the first quarter of 2005, total revenues were $775,000, . . .
PPD REPORTS FIRST QTR '05 NET REVENUE OF $244.1
MILLION.
For the first quarter of 2005, PPD has recorded net revenue of
$244.1 million, an increase of 25.0 percent over net revenue of $195.3
million for the first quarter of 2004. Net revenue for the . . .
SUNWIN REPORTS 19% REVENUE INCREASE TO US $9.163 MILLION.(Sunwin
International Neutraceuticals Inc)
Sunwin International Neutraceuticals, Inc. (OTCBB:SUWN), an
industry leader in distribution and manufacturing of Chinese herbs,
veterinary medicines and low calorie natural sweetener (Stevia) . . .
ZILA FISCAL 2005 2ND QTR NET REVENUES DECREASE 2%.
Zila, Inc., Phoenix, (Nasdaq:ZILA) has announced results for its
second quarter of fiscal 2005 that ended January 31, 2005. Highlights of
those results, compared with the second quarter of fiscal . . .
CHELSEA THERAPEUTICS COMPLETES $14.5 MIL PRIVATE
PLACEMENT.
Chelsea Therapeutics, Inc., Charlotte, N.C., a privately held
development-stage biopharmaceutical company, has completed a private
placement of Series A Convertible Preferred Stock, resulting in . . .
BODISEN BIOTECH REPORTS 1ST QTR '05 EARNINGS INCREASED
166%.(Bodisen Biotech Inc)
Bodisen Biotech, Inc., (OTCBB: BBOI) has recorded substantial
growth in sales for the first quarter of 2005. The following are some of
the key financial highlights for the period ended Mar. 31, . . .
CRUCELL REPORTS FIRST QTR 2005 REVENUE UP 50% OVER 2004.
Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL),
has announced its financial results for the first quarter of 2005.
Crucell's revenue for the first quarter was US$ 7.7 million, up . . .
MONSANTO BUYS ICORIA AGRICULTURAL ASSETS FOR $6.75
MILLION.
Monsanto Company (NYSE:MON) and Icoria, Inc. (NASDAQ:ICOR) has
announced that Monsanto has acquired selected agricultural assets of
biotechnology research company Icoria for $6.75 million in . . .
BIOVAIL PROVIDES 2005 GUIDANCE AND STRATEGY UPDATE.
Biovail Corporation (NYSE:BVF)(TSX:BVF), Toronto, has announced its
revenues and earnings guidance for 2005. The financial guidance reflects
the company's strength in leveraging its drug-delivery . . .
MEDICIS REPORTS 2ND QTR FISCAL '05 NET REVENUE GROWTH OF
31%.(Medicis Pharmaceutical Corp.)
Medicis (NYSE:MRX), Scottsdale, Ariz., has announced second quarter
fiscal 2005 net revenue growth of approximately 31% to $92.3 million
with "if-converted" net income of $25.4 million, or $0.36 . . .
GERON REPORTS NET LOSS OF $9.7 MILLION FOR FIRST QTR
2005.
For the first quarter of 2005, Geron Corporation has reported
operating revenue of $59,000 and operating expenses of $10.4 million
compared to $248,000 and $52.3 million, respectively, for the . . .
ZYMEX MEDICAL CONTINUED REVENUE GROWTH IN FEBRUARY.(Zynex Medical
Holdings )(Brief Article)
Zynex Medical Holdings (OTCBB:ZYNX), Littleton, Colo., has
announced its February 2005 net revenue of $166,720 as part of its
preliminary financial results for February of 2005. Compared to . . .
BIOTECHNOLOGY IN "NEW" EU COUNTRIES OFFERS GOOD
POTENTIAL.
In contrast to subdued growth in the pharmaceutical markets of the
former 15-state European Union (EU), pharmaceutical markets in the
"new" EU accession markets are expanding vibrantly. While . . .
ORPHAN MEDICAL EXPECTS 2005 REVENUE TO EXCEED $35
MILLION.
Orphan Medical, Inc. (Nasdaq:ORPH), Minneapolis, Minn., announced
that 8,928 Xyrem(R) prescriptions were filled during the fourth quarter
ended December 31, 2004, an increase of 9 percent from the . . .
ARROW REPORTS FIRST QTR 2005 NET INCOME OF $13.6 MILLION.
Arrow International, Inc. (NASDAQ:ARRO), Reading, Pa., has reported
net sales of $113.2 million for the fiscal quarter ended November 30,
2004, an increase of 9.8%, or $10.1 million, versus its . . .
|
|